ITGR Integer Holdings Corporation Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 4, 2026
$126,45
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$62,0052tyg. minimum
$126,8052tyg. maksimum
Kapitalizacja Rynkowa
$4.34B
P/E (TTM)
34.4
EPS (TTM)
$3.68
Przychody (TTM)
$1.84B
Twoje odznaki
Zakres 52 tyg.
$62–$127
Ocena Analityków
HOLD
Cena Docelowa
$122
P/E
34.4
ROE
6.0%
Marża Zysku Netto
7.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
ITGR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$126.45
Kapitalizacja Rynkowa
$4.34B
P/E (TTM)
34.4
EPS (TTM)
$3.68
Przychody (TTM)
$1.84B
ROE
6.0%
D/E Dług/Kapitał
0.7
Zakres 52 tyg.
$62–$127
ITGR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$1.85B2016-12-30 → 2025-12-31
EPS$2.892016-12-30 → 2025-12-31
Wolny przepływ pieniężny$105M2016-12-30 → 2025-12-31
Marża netto7.0%2016-12-30 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ITGR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 34.4średnia z 5 lat ≈33.4 | ≈33.4 | 28.6 | Niedowartościowany | |
| P/S | 2.3średnia z 5 lat ≈2.0 | ≈2.0 | 3.9 | Niedowartościowany | |
| P/B | 2.5średnia z 5 lat ≈2.0 | ≈2.0 | 7.4 | Niedowartościowany | |
| EV / EBITDA | 15.7średnia z 5 lat ≈14.6 | ≈14.6 | · | · | |
| Price / FCF (Cena / FCF) | 41.3średnia z 5 lat ≈41.4 | ≈41.4 | · | · | |
| Price / Cash Flow (Cena / Przepływy pieniężne) | 22.1średnia z 5 lat ≈18.3 | ≈18.3 | 26.2 | Niedowartościowany | |
| EV / Revenue (EV / Przychody) | 3.0średnia z 5 lat ≈2.6 | ≈2.6 | · | · | |
| EV / FCF | 52.4średnia z 5 lat ≈53.7 | ≈53.7 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈7.8 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ITGR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 25.7%średnia z 5 lat ≈26.7% | ≈26.7% | 58.7% | Słaby | |
| Marża Operacyjna (TTM) | 9.7%średnia z 5 lat ≈10.9% | ≈10.9% | 9.2% | Poniżej średniej | |
| EBITDA Margin (Marża EBITDA) | 19.0%średnia z 5 lat ≈17.5% | ≈17.5% | 10.1% | Poniżej średniej | |
| Marża przed opodatkowaniem (TTM) | 7.4%średnia z 5 lat ≈7.2% | ≈7.2% | 9.0% | Słaby | |
| Marża Zysku Netto (TTM) | 7.0%średnia z 5 lat ≈6.2% | ≈6.2% | 6.2% | Poniżej średniej | |
| ROA | 3.2%średnia z 5 lat ≈3.3% | ≈3.3% | -1.9% | Najwyższa półka | |
| ROE | 6.0%średnia z 5 lat ≈6.3% | ≈6.3% | -11.5% | Najwyższa półka | |
| ROIC | 6.2%średnia z 5 lat ≈5.7% | ≈5.7% | 4.9% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ITGR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Debt / Equity (Dług / Kapitał Własny) | 0.7średnia z 5 lat ≈0.6 | ≈0.6 | 0.5 | Wysokie zadłużenie | |
| Current Ratio (Wskaźnik bieżący) | 3.3średnia z 5 lat ≈2.9 | ≈2.9 | 3.6 | Zgodnie z | |
| Quick Ratio (Wskaźnik Szybkości) | 1.6średnia z 5 lat ≈1.2 | ≈1.2 | 2.2 | Niska płynność | |
| Long-Term Debt / Equity (Dług długoterminowy / Kapitał własny) | 0.7średnia z 5 lat ≈0.6 | ≈0.6 | 0.6 | Wysokie zadłużenie |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ITGR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 8.0%średnia z 5 lat ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 11.7%średnia z 5 lat ≈12.3% | ≈12.3% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 11.5% | · | · | · | |
| EPS YoY | -14.0%średnia z 5 lat ≈7.9% | ≈7.9% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -14.2%średnia z 5 lat ≈9.7% | ≈9.7% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 13.2%średnia z 5 lat ≈7.7% | ≈7.7% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 4.4% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 15.7%średnia z 5 lat ≈9.5% | ≈9.5% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 5.9% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ITGR | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.5 | ≈0.5 | 0.5 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 5.4średnia z 5 lat ≈5.5 | ≈5.5 | 3.0 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 6.3średnia z 5 lat ≈6.9 | ≈6.9 | 6.1 | Zgodnie z | |
| Revenue / Employee (Przychody / pracownika) | ≈$168.5K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
3.1%
Następny raport
Paź 21, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 6, 2026 | $1.60 | $1.44 | 10.9% |
| 31 marca 2026 | $1.20 | $1.21 | -0.84% | |
| 31 grudnia 2025 | $1.76 | $1.73 | 1.6% | |
| 30 września 2025 | $1.79 | $1.71 | 4.7% | |
| 30 czerwca 2025 | $1.55 | $1.58 | -2.0% | |
| 31 marca 2025 | $1.31 | $1.26 | 4.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.85B | $1.72B | $1.56B | $1.33B | $1.22B | $1.07B | $1.26B | $1.22B | $1.14B | $1.08B | $800M | $688M | |
| Cost of Revenue | $1.35B | $1.26B | $1.15B | $986M | $884M | $788M | $903M | $852M | $782M | $738M | $565M | $456M | |
| Gross Profit | $500M | $459M | $410M | $346M | $337M | $286M | $355M | $363M | $354M | $338M | $235M | $231M | |
| SG&A Expense | $212M | $185M | $173M | $158M | $141M | $109M | $139M | $142M | $143M | $136M | $103M | $91M | |
| Operating Expenses | $279M | $251M | $247M | $233M | $201M | $165M | $197M | $207M | $228M | $245M | $222M | $156M | |
| Operating Income | $221M | $208M | $163M | $113M | $136M | $121M | $158M | $156M | $126M | $93M | $13M | $76M | |
| Interest Expense | · | · | $53M | $39M | $32M | $38M | $53M | $99M | $64M | $68M | $34M | $4M | |
| Other Non-op | $-53M | $-4M | $-975.0K | $899.0K | $123.0K | $-2M | $578.0K | $-752.0K | $-11M | $4M | $1M | $807.0K | |
| Pretax Income | $125M | $148M | $105M | $69M | $101M | $86M | $105M | $61M | $49M | $28M | $-16M | $77M | |
| Income Tax | $23M | $27M | $16M | $9M | $8M | $9M | $14M | $14M | $-38M | $3M | $-8M | $21M | |
| Net Income | $103M | $120M | $91M | $66M | $97M | $77M | $96M | $168M | $67M | $6M | $-8M | $55M | |
| EPS (Basic) | $2.96 | $3.57 | $2.72 | $2.00 | $2.93 | $2.35 | $2.95 | $5.23 | $2.12 | $0.19 | $-0.29 | $2.23 | |
| EPS (Diluted) | $2.89 | $3.36 | $2.69 | $1.99 | $2.91 | $2.33 | $2.92 | $5.15 | $2.08 | $0.19 | $-0.29 | $2.14 | |
| Shares (Basic) | 34,735,000 | 33,601,000 | 33,320,000 | 33,127,000 | 32,993,000 | 32,845,000 | 32,627,000 | 32,136,000 | 31,402,000 | 30,778,000 | 26,363,000 | 24,825,000 | |
| Shares (Diluted) | 35,594,000 | 35,649,000 | 33,758,000 | 33,357,000 | 33,258,000 | 33,113,000 | 33,037,000 | 32,596,000 | 32,056,000 | 30,973,000 | 26,363,000 | 25,975,000 | |
| EBITDA | $352M | $319M | $266M | $213M | $217M | $200M | $236M | $245M | $242M | $199M | $58M | $113M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $47M | $24M | $24M | $18M | $49M | $14M | $26M | $44M | $52M | $82M | $77M | |
| Receivables | $346M | $245M | $231M | $224M | $182M | $156M | $192M | $186M | $195M | $205M | $207M | $125M | |
| Inventory | $254M | $247M | $229M | $209M | $156M | $149M | $167M | $190M | $177M | $225M | $252M | $129M | |
| Prepaid Expense | $41M | $28M | $30M | $27M | $28M | $16M | $18M | $15M | $16M | $22M | $21M | $12M | |
| Current Assets | $770M | $671M | $618M | $558M | $453M | $413M | $415M | $416M | $532M | $517M | $575M | $351M | |
| PP&E (Net) | $536M | $466M | $393M | $317M | $277M | $254M | $246M | $231M | $235M | $372M | $379M | $145M | |
| PP&E (Gross) | $1.11B | $968M | $845M | $755M | $683M | $626M | $581M | $532M | $509M | $649M | $612M | $359M | |
| Accum. Depreciation | $569M | $502M | $452M | $438M | $406M | $372M | $335M | $300M | $273M | $277M | $232M | $214M | |
| Goodwill | $1.11B | $1.02B | $994M | $965M | $925M | $859M | $840M | $832M | $840M | $967M | $1.01B | $354M | |
| Intangibles | $825M | $778M | $780M | $820M | $808M | $757M | $776M | $812M | $863M | $940M | $894M | $65M | |
| Other Non-current Assets | $23M | $23M | $22M | $27M | $36M | $39M | $29M | $31M | $30M | $32M | $27M | $17M | |
| Total Assets | $3.41B | $3.08B | $2.94B | $2.79B | $2.58B | $2.37B | $2.35B | $2.33B | $2.85B | $2.83B | $2.98B | $955M | |
| Accounts Payable | $113M | $101M | $118M | $111M | $77M | $52M | $65M | $57M | $65M | $78M | $84M | $46M | |
| Accrued Liabilities | $110M | $108M | $91M | $73M | $57M | $57M | $66M | $60M | $60M | $72M | $97M | $48M | |
| Current Liabilities | $232M | $227M | $221M | $224M | $160M | $156M | $179M | $165M | $209M | $185M | $214M | $109M | |
| Capital Leases | $82M | $78M | $72M | $64M | $60M | $38M | $37M | $0 | · | · | · | · | |
| Deferred Tax | $116M | $125M | $144M | $161M | $172M | $182M | $188M | $204M | $141M | $209M | $222M | $53M | |
| Other Non-current Liabilities | $20M | $25M | $14M | $13M | $16M | $31M | $19M | $10M | $11M | $15M | $11M | $5M | |
| Total Liabilities | $1.66B | $1.46B | $1.42B | $1.38B | $1.23B | $1.10B | $1.20B | $1.27B | $1.95B | $2.11B | $2.13B | $342M | |
| Long-term Debt | $1.19B | $990M | $960M | $925M | $828M | $731M | $815M | $926M | $1.61B | $1.73B | $1.71B | $187M | |
| Total Debt | $1.19B | $990M | $960M | $925M | $828M | $731M | $815M | $926M | $1.61B | $1.73B | $1.71B | $188M | |
| Common Stock | $35.0K | $34.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $32.0K | $31.0K | $31.0K | $25.0K | |
| Retained Earnings | $994M | $891M | $771M | $681M | $614M | $518M | $440M | $344M | $176M | $109M | $232M | $239M | |
| Treasury Stock | $77M | $0 | $0 | · | · | $0 | $9M | $8M | $5M | $6M | $3M | $1M | |
| AOCI | $58M | $-14M | $20M | $5M | $27M | $53M | $20M | $33M | $52M | $-16M | $1M | $9M | |
| Stockholders' Equity | $1.75B | $1.62B | $1.52B | $1.42B | $1.35B | $1.27B | $1.15B | $1.06B | $893M | $725M | $851M | $613M | |
| Liabilities + Equity | $3.41B | $3.08B | $2.94B | $2.79B | $2.58B | $2.37B | $2.35B | $2.33B | $2.85B | $2.83B | $2.98B | $955M | |
| Shares Outstanding | 34,346,450 | 33,546,256 | 33,329,648 | 33,169,778 | 33,063,336 | 32,908,178 | 32,700,471 | 32,473,167 | 31,871,427 | 30,925,496 | 30,601,167 | 25,070,931 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $131M | $111M | $99M | $92M | $81M | $79M | $78M | $89M | $103M | $91M | $45M | $37M | |
| Stock-based Comp | $23M | $25M | $23M | $21M | $16M | $9M | $9M | $10M | $15M | $8M | $9M | $13M | |
| Deferred Tax | $-3M | $-14M | $-9M | $-17M | $-10M | $-7M | $-10M | $4M | $-45M | $-7M | $-10M | $531.0K | |
| Amort. of Intangibles | $64M | $55M | $53M | $48M | $42M | $41M | $40M | $41M | $43M | $35M | $17M | $14M | |
| Restructuring | $2M | $4M | $6M | $4M | $5M | $4M | · | · | · | · | · | · | |
| Other Non-cash | $-58M | $-36M | $-23M | $-46M | $-26M | $23M | $-8M | $-161M | $24M | $8M | $-24M | $-25M | |
| Operating Cash Flow | $196M | $205M | $180M | $116M | $157M | $181M | $165M | $167M | $149M | $106M | $12M | $81M | |
| CapEx | $91M | $105M | $120M | $75M | $53M | $47M | $48M | $45M | $47M | $59M | $45M | $25M | |
| Investing Cash Flow | $-271M | $-195M | $-163M | $-200M | $-271M | $-57M | $-59M | $537M | $-48M | $-63M | $-474M | $-36M | |
| Debt Issued | $978M | $0 | $486M | $0 | $818M | $0 | $0 | $5M | $50M | $57M | $1.75B | $0 | |
| Net Debt Issued | $310M | $0 | · | $0 | $818M | · | · | $-700M | $-129M | $11M | $518M | $-10M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $3M | $7M | $8M | |
| Stock Repurchased | $50M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-50M | · | · | · | · | · | · | · | · | $3M | $7M | $8M | |
| Financing Cash Flow | $44M | $13M | $-18M | $92M | $82M | $-89M | $-118M | $-725M | $-112M | $-72M | $468M | $-2M | |
| Net Change in Cash | $-29M | $23M | $-598.0K | $6M | $-31M | $36M | $-12M | $-19M | $-8M | $-30M | $6M | $41M | |
| Taxes Paid | $28M | $36M | $30M | $11M | $20M | $18M | $30M | $23M | $-8M | $7M | $6M | · | |
| Free Cash Flow | $105M | $100M | $60M | $42M | $103M | $135M | $117M | $122M | $102M | $47M | $-32M | $56M | |
| Levered FCF | · | · | $15M | $8M | $74M | $100M | $72M | $46M | $-223M | $-513M | $-48M | $53M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.0% | 26.7% | 26.2% | 26.1% | 27.6% | 26.6% | 28.2% | 29.8% | 26.9% | 27.3% | 29.4% | 33.6% | |
| Operating Margin | 11.9% | 12.1% | 10.5% | 8.8% | 11.1% | 11.2% | 12.5% | 12.8% | 9.5% | 7.8% | 1.6% | 11.0% | |
| Net Margin | 5.5% | 7.0% | 5.7% | 4.8% | 7.9% | 7.2% | 7.7% | 13.8% | 4.6% | 0.43% | -0.95% | 8.1% | |
| Pretax Margin | 6.8% | 8.6% | 6.7% | 5.5% | 8.3% | 8.0% | 8.4% | 5.0% | 1.5% | 0.09% | -2.0% | 11.1% | |
| EBITDA Margin | 19.0% | 18.6% | 16.7% | 15.5% | 17.8% | 18.6% | 18.7% | 20.1% | 16.6% | 14.3% | 7.2% | 16.4% | |
| ROA | 3.2% | 4.0% | 3.2% | 2.5% | 3.9% | 3.3% | 4.1% | 6.5% | 2.4% | 0.21% | -0.39% | 6.0% | |
| ROE | 6.0% | 7.4% | 6.1% | 4.8% | 7.2% | 6.2% | 8.5% | 16.0% | 8.2% | 0.76% | -1.0% | 9.4% | |
| ROIC | 6.2% | 6.6% | 5.7% | 4.5% | 5.7% | 5.4% | 7.0% | 6.0% | 17.0% | 22.2% | 0.25% | 6.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.0 | 2.8 | 2.5 | 2.8 | 2.6 | 2.3 | 2.5 | 2.5 | 2.8 | 2.7 | 3.2 | |
| Quick Ratio | 1.6 | 1.3 | 1.2 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.4 | 1.4 | 1.4 | 1.9 | |
| Debt / Equity | 0.7 | 0.6 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.9 | 1.8 | 2.4 | 2.0 | 0.3 | |
| LT Debt / Equity | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.7 | 0.8 | 1.8 | 2.3 | 2.0 | 0.3 | |
| Interest Coverage | · | · | 3.1 | 3.1 | 4.3 | 3.2 | 3.0 | 1.6 | 1.3 | 1.0 | 0.4 | 17.8 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 | |
| Inventory Turnover | 5.4 | 5.3 | 5.3 | 5.6 | 5.8 | 5.0 | 5.1 | 4.6 | 4.7 | 4.2 | 3.0 | 3.7 | |
| Receivables Turnover | 6.3 | 7.2 | 6.9 | 6.8 | 7.2 | 6.2 | 6.7 | 6.4 | 6.5 | 6.7 | 4.8 | 5.7 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $50.85 | $48.27 | $45.58 | $42.73 | $40.97 | $38.62 | $35.24 | $32.66 | $28.03 | $23.45 | $27.80 | $24.47 | |
| Revenue / Share | $52.08 | $48.15 | $47.30 | $41.25 | $36.72 | $32.42 | $38.08 | $37.27 | $45.85 | $44.77 | $30.36 | $26.48 | |
| Cash Flow / Share | $5.51 | $5.76 | $5.34 | $3.49 | $4.71 | $5.48 | $5.01 | $5.13 | $4.68 | $3.41 | $0.47 | $3.13 | |
| Cash / Share | $0.50 | $1.39 | $0.71 | · | · | · | · | $0.79 | $1.38 | $1.69 | $2.70 | $3.06 | |
| EPS (TTM) | $2.89 | $3.36 | $2.69 | $1.99 | $2.91 | $2.33 | $2.92 | $5.15 | $2.08 | $0.19 | $-0.29 | $2.14 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.0% | 10.3% | 16.9% | 9.0% | 13.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.7% | 12.0% | 13.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.0% | 24.9% | 35.2% | -31.6% | 24.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 13.2% | 4.9% | 4.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 4.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -14.2% | 32.3% | 36.6% | -31.4% | 25.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.7% | 7.4% | 5.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.85B | $1.72B | $1.56B | $1.33B | $1.22B | $1.07B | $1.26B | $1.22B | $1.14B | $1.08B | $800M | $688M | |
| Net Income TTM | $103M | $120M | $91M | $66M | $97M | $77M | $96M | $168M | $67M | $6M | $-8M | $55M | |
| Market Cap | $2.69B | $4.45B | $3.30B | $2.27B | $2.83B | $2.67B | $2.63B | $2.47B | $1.44B | $911M | $1.46B | $1.11B | |
| Enterprise Value | $3.86B | $5.39B | $4.24B | · | · | · | · | $3.37B | $3.01B | $2.59B | $3.10B | $1.22B | |
| P/E | 27.1 | 39.4 | 36.8 | 34.4 | 29.4 | 34.8 | 27.5 | 14.8 | 21.8 | 155.0 | -165.0 | 20.7 | |
| P/S | 1.5 | 2.6 | 2.1 | 1.7 | 2.3 | 2.5 | 2.1 | 2.0 | 1.3 | 0.8 | 1.8 | 1.6 | |
| P/B | 1.5 | 2.7 | 2.2 | 1.6 | 2.1 | 2.1 | 2.3 | 2.3 | 1.6 | 1.3 | 1.7 | 1.8 | |
| P / Cash Flow | 13.7 | 21.7 | 18.3 | 19.5 | 18.1 | 14.7 | 15.9 | 14.8 | 9.7 | 8.6 | 117.4 | 13.7 | |
| P / FCF | 25.6 | 44.5 | 54.8 | 54.5 | 27.4 | 19.9 | 22.4 | 20.2 | 14.1 | 19.4 | -45.6 | 19.7 | |
| EV / EBITDA | 11.0 | 16.9 | 15.9 | · | · | · | · | 13.8 | 12.4 | 13.0 | 53.6 | 10.8 | |
| EV / FCF | 36.7 | 54.0 | 70.3 | · | · | · | · | 27.5 | 29.5 | 55.2 | -96.3 | 21.7 | |
| EV / Revenue | 2.1 | 3.1 | 2.7 | · | · | · | · | 2.8 | 2.6 | 2.4 | 3.9 | 1.8 | |
| Earnings Yield | 3.7% | 2.5% | 2.7% | 2.9% | 3.4% | 2.9% | 3.6% | 6.8% | 4.6% | 0.65% | -0.61% | 4.8% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $464M | $440M | $472M | $468M | $476M | $437M | $449M | $431M | $428M | $408M | $380M | $397M | $400M | $379M | $328M | $343M | |
| Cost of Revenue | $351M | $330M | $347M | $342M | $347M | $317M | $333M | $315M | $311M | $300M | $278M | $292M | $294M | $282M | $243M | $256M | |
| Gross Profit | $113M | $110M | $125M | $126M | $129M | $120M | $117M | $117M | $117M | $108M | $102M | $105M | $106M | $97M | $85M | $87M | |
| SG&A Expense | $58M | $59M | $57M | $50M | $53M | $51M | $47M | $45M | $46M | $46M | $44M | $41M | $46M | $42M | $39M | $38M | |
| Operating Expenses | $78M | $78M | $69M | $70M | $70M | $71M | $60M | $59M | $63M | $70M | $64M | $56M | $64M | $63M | $56M | $57M | |
| Operating Income | $35M | $32M | $56M | $56M | $59M | $50M | $57M | $58M | $54M | $39M | $39M | $49M | $42M | $34M | $28M | $29M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $15M | · | $12M | $11M | $17M | · | $11M | |
| Other Non-op | $-1M | $-316.0K | $-175.0K | $-1M | $-4M | $-48M | $-2M | $-916.0K | $127.0K | $-1M | $724.0K | $-580.0K | $-359.0K | $-760.0K | $-33.0K | $1M | |
| Pretax Income | $23M | $20M | $47M | $46M | $46M | $-13M | $39M | $43M | $40M | $25M | $26M | $33M | $30M | $16M | $13M | $17M | |
| Income Tax | $-314.0K | $4M | $-2M | $6M | $9M | $9M | $6M | $7M | $9M | $4M | $2M | $5M | $6M | $3M | $2M | $938.0K | |
| Net Income | $24M | $17M | $49M | $40M | $37M | $-22M | $33M | $35M | $31M | $21M | $26M | $27M | $24M | $13M | $18M | $16M | |
| EPS (Basic) | $0.69 | $0.48 | $1.43 | $1.13 | $1.06 | $-0.66 | $0.98 | $1.05 | $0.93 | $0.61 | $0.79 | $0.82 | $0.72 | $0.39 | $0.54 | $0.48 | |
| EPS (Diluted) | $0.69 | $0.48 | $1.40 | $1.11 | $1.04 | $-0.66 | $0.90 | $0.99 | $0.88 | $0.59 | $0.78 | $0.81 | $0.71 | $0.39 | $0.54 | $0.48 | |
| Shares (Basic) | 34,010,000 | 34,278,000 | · | 35,081,000 | 35,035,000 | 33,916,000 | · | 33,656,000 | 33,600,000 | 33,478,000 | · | 33,346,000 | 33,312,000 | 33,258,000 | · | 33,145,000 | |
| Shares (Diluted) | 34,145,000 | 34,433,000 | · | 35,608,000 | 35,713,000 | 33,916,000 | · | 35,791,000 | 35,529,000 | 34,993,000 | · | 33,774,000 | 33,686,000 | 33,575,000 | · | 33,336,000 | |
| EBITDA | $35M | $67M | · | · | $59M | $79M | · | $58M | $55M | $65M | · | $48M | $42M | $58M | · | $29M |
Bilans
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $8M | $17M | $59M | $23M | $32M | $47M | $36M | $34M | $42M | · | $32M | $39M | $41M | · | $20M | |
| Receivables | $339M | $328M | $346M | $310M | $302M | $276M | $245M | $242M | $241M | $237M | · | $226M | $237M | $251M | · | $216M | |
| Inventory | $288M | $284M | $254M | $264M | $266M | $260M | $247M | $265M | $272M | $263M | · | $232M | $229M | $225M | · | $210M | |
| Prepaid Expense | $43M | $39M | $41M | $38M | $42M | $31M | $28M | $25M | $24M | $33M | · | $27M | $29M | $30M | · | $29M | |
| Current Assets | $811M | $775M | $770M | $778M | $737M | $702M | $671M | $730M | $677M | $669M | · | $609M | $616M | $629M | · | $557M | |
| PP&E (Net) | $532M | $533M | $536M | · | · | · | $466M | $472M | $466M | $449M | · | $364M | $349M | $331M | · | $282M | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $968M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $569M | · | · | · | $502M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1.10B | $1.11B | $1.11B | $1.10B | $1.10B | $1.08B | $1.02B | $1.03B | $1.04B | $1.04B | $994M | $980M | $986M | $987M | $965M | $965M | |
| Intangibles | $789M | $806M | $825M | $838M | $855M | $856M | $778M | $805M | $814M | $829M | · | $779M | $798M | $811M | · | $816M | |
| Other Non-current Assets | $39M | $40M | $23M | $25M | $26M | $23M | $23M | $24M | $22M | $23M | · | $25M | $28M | $28M | · | $39M | |
| Total Assets | $3.42B | $3.41B | $3.41B | $3.40B | $3.37B | $3.30B | $3.08B | $3.17B | $3.13B | $3.12B | · | $2.84B | $2.86B | $2.87B | · | $2.74B | |
| Accounts Payable | $112M | $115M | $113M | $111M | $117M | $112M | $101M | $117M | $119M | $116M | · | $108M | $108M | $124M | · | $101M | |
| Accrued Liabilities | $97M | $83M | $110M | $90M | $90M | $86M | $108M | $86M | $77M | $71M | · | $82M | $74M | $70M | · | $70M | |
| Current Liabilities | $217M | $206M | $232M | $210M | $216M | $206M | $227M | $222M | $206M | $201M | · | $203M | $200M | $225M | · | $199M | |
| Capital Leases | $67M | $69M | $82M | $83M | $84M | $86M | $78M | $69M | $72M | $74M | · | $57M | $60M | $62M | · | $62M | |
| Deferred Tax | $115M | $115M | $116M | $115M | $115M | $111M | $125M | $143M | $144M | $145M | · | $151M | $153M | $153M | · | $177M | |
| Other Non-current Liabilities | $17M | $20M | $20M | $25M | $24M | $28M | $25M | $23M | $18M | $18M | · | $15M | $15M | $15M | · | $22M | |
| Total Liabilities | $1.70B | $1.71B | $1.66B | $1.65B | $1.67B | $1.69B | $1.46B | $1.55B | $1.57B | $1.59B | · | $1.38B | $1.42B | $1.46B | · | $1.38B | |
| Long-term Debt | $1.24B | $1.25B | $1.19B | $1.19B | $1.20B | $1.24B | $990M | $1.08B | $1.12B | $1.14B | · | $941M | $985M | $1.00B | · | $939M | |
| Total Debt | · | · | · | · | $1.20B | $1.24B | · | $1.08B | $1.12B | $1.14B | · | $941M | $985M | $1.00B | · | $939M | |
| Common Stock | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | · | $33.0K | $33.0K | $33.0K | · | $33.0K | |
| Retained Earnings | $1.03B | $1.01B | $994M | $945M | $906M | $869M | $891M | $859M | $823M | $792M | · | $745M | $718M | $694M | · | $663M | |
| Treasury Stock | $111M | $114M | $77M | $27M | $27M | $27M | $0 | $0 | · | · | · | · | · | · | · | · | |
| AOCI | $39M | $45M | $58M | $62M | $64M | $11M | $-14M | $26M | $614.0K | $8M | · | $-3M | $12M | $15M | · | $-35M | |
| Stockholders' Equity | $1.72B | $1.70B | $1.75B | $1.75B | $1.70B | $1.61B | $1.62B | $1.62B | $1.55B | $1.53B | $1.52B | $1.46B | $1.45B | $1.42B | $1.42B | $1.36B | |
| Liabilities + Equity | $3.42B | $3.41B | $3.41B | $3.40B | $3.37B | $3.30B | $3.08B | $3.17B | $3.13B | $3.12B | · | $2.84B | $2.86B | $2.87B | · | $2.74B | |
| Shares Outstanding | 33,992,048 | 33,945,540 | 34,346,450 | 35,038,156 | 35,034,817 | 34,889,876 | 33,546,256 | 33,541,478 | 33,531,179 | 33,503,719 | · | 33,326,647 | 33,308,080 | 33,265,390 | · | 33,130,993 |
Przepływy pieniężne
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $35M | $36M | $33M | $32M | $30M | $29M | $29M | $27M | $26M | $26M | $25M | $24M | $24M | $23M | $23M | |
| Stock-based Comp | · | $7M | $6M | $5M | $6M | $7M | $6M | $6M | $6M | $7M | $6M | $5M | $6M | $6M | $5M | $5M | |
| Deferred Tax | · | $17.0K | $-7M | $140.0K | $-113.0K | $4M | $-14M | $0 | $0 | $0 | $-9M | $-1.0K | $1.0K | $-5.0K | $-17M | $0 | |
| Amort. of Intangibles | $16M | $16M | $17M | $16M | $16M | $15M | $14M | $14M | $14M | $13M | $14M | $13M | $13M | $13M | $12M | $12M | |
| Restructuring | $2M | $607.0K | $281.0K | $702.0K | $637.0K | $664.0K | $982.0K | $714.0K | $907.0K | $1M | $4M | $-103.0K | $936.0K | $1M | $991.0K | $2M | |
| Other Non-cash | · | $-34M | · | · | · | $13M | · | · | · | $-30M | · | · | · | $-37M | · | · | |
| Operating Cash Flow | · | $25M | $55M | $66M | $44M | $31M | $63M | $72M | $47M | $23M | $56M | $62M | $56M | $6M | $52M | $28M | |
| CapEx | · | $24M | $27M | $19M | $19M | $25M | $19M | $26M | $31M | $29M | $37M | $25M | $33M | $25M | $32M | $20M | |
| Investing Cash Flow | · | $-38M | $-35M | $-20M | $-18M | $-197M | $30M | $-26M | $-31M | $-168M | $-81M | $-25M | $-33M | $-25M | $-31M | $-20M | |
| Debt Issued | · | $0 | $0 | $0 | $0 | $978M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $486M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $364M | · | · | · | $0 | · | · | · | $95M | · | · | |
| Stock Repurchased | · | $50M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | $4M | $-62M | $-11M | $-36M | $152M | $-82M | $-43M | $-25M | $163M | $18M | $-43M | $-26M | $33M | $-14M | $-9M | |
| Net Change in Cash | · | $-9M | $-42M | $36M | $-9M | $-15M | $11M | $1M | $-8M | $18M | $-8M | $-6M | $-2M | $16M | $4M | $5M | |
| Free Cash Flow | · | $737.0K | · | · | · | $6M | · | · | · | $-6M | · | · | · | $-19M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-18M | · | · | · | $-33M | · | · |
Rentowność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.3% | 24.9% | · | · | 27.1% | 27.5% | · | 27.0% | 27.4% | 26.5% | · | 26.1% | 26.5% | 25.5% | · | 25.3% | |
| Operating Margin | 7.4% | 7.2% | · | · | 12.4% | 11.3% | · | 13.5% | 12.7% | 9.5% | · | 11.9% | 10.4% | 9.0% | · | 8.5% | |
| Net Margin | 5.1% | 3.8% | · | · | 7.8% | -5.1% | · | 8.2% | 7.2% | 4.9% | · | 6.7% | 6.0% | 3.5% | · | 4.7% | |
| Pretax Margin | 5.0% | 4.6% | · | · | 9.6% | -3.0% | · | 10.1% | 9.2% | 6.0% | · | 7.9% | 7.5% | 4.2% | · | 5.0% | |
| EBITDA Margin | 7.4% | 15.2% | · | · | 12.4% | 18.1% | · | 13.5% | 12.7% | 15.8% | · | 11.9% | 10.4% | 15.4% | · | 8.5% | |
| ROA | · | · | · | · | 1.1% | -0.70% | · | 1.2% | 1.0% | 0.68% | · | 0.98% | 0.85% | 0.48% | · | 0.63% | |
| ROE | · | · | · | · | 2.3% | -1.4% | · | 2.3% | 2.1% | 1.4% | · | 1.9% | 1.7% | 0.94% | · | 1.2% | |
| ROIC | · | · | · | · | 1.7% | 3.0% | · | 1.8% | 1.6% | 1.2% | · | 1.7% | 1.4% | 1.1% | · | 1.2% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 3.4 | 3.4 | · | 3.3 | 3.3 | 3.3 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Quick Ratio | · | · | · | · | 1.5 | 1.5 | · | 1.2 | 1.3 | 1.4 | · | 1.3 | 1.4 | 1.3 | · | 1.2 | |
| Debt / Equity | · | · | · | · | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | · | · | · | · | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 2.7 | · | 4.0 | 3.6 | 2.0 | · | 2.7 |
Efektywność
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | 1.3 | 1.2 | · | 1.3 | 1.3 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | |
| Receivables Turnover | · | · | · | · | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.7 | · | 1.8 | 1.7 | 1.7 | · | 1.7 |
Na akcję
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $48.62 | $46.05 | · | $48.33 | $46.34 | $45.52 | · | $43.91 | $43.40 | $42.62 | · | $40.90 | |
| Revenue / Share | $13.59 | $12.77 | · | · | $13.34 | $12.90 | · | $12.05 | $12.28 | $11.85 | · | $11.98 | $11.88 | $11.28 | · | $10.28 | |
| Cash Flow / Share | · | $0.72 | · | · | · | $0.92 | · | · | · | $0.66 | · | · | · | $0.18 | · | · | |
| Cash / Share | · | · | · | · | $0.66 | $0.91 | · | $1.06 | $1.02 | $1.26 | · | $0.96 | $1.16 | $1.22 | · | $0.61 | |
| EPS (TTM) | $3.68 | $4.03 | · | $2.48 | $2.27 | $2.11 | · | $3.24 | $3.06 | $2.89 | · | $2.45 | $2.12 | $2.03 | · | $2.15 |
Wycena (TTM)
| Wskaźnik | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.84B | $1.86B | · | $1.81B | $1.79B | $1.75B | · | $1.65B | $1.61B | $1.58B | · | $1.50B | $1.45B | $1.40B | · | $1.32B | |
| Net Income TTM | $128M | $142M | · | $90M | $83M | $77M | · | $114M | $105M | $98M | · | $82M | $71M | $68M | · | $72M | |
| Market Cap | · | · | · | · | $4.29B | $4.08B | · | $4.22B | $3.88B | $3.91B | · | $2.61B | $2.95B | $2.58B | · | $2.06B | |
| Enterprise Value | · | · | · | · | $5.47B | $5.28B | · | $5.27B | $4.97B | $5.01B | · | $3.52B | $3.90B | $3.54B | · | $2.98B | |
| P/E | 25.9 | 21.6 | · | 40.9 | 54.0 | 55.4 | · | 38.9 | 37.8 | 40.4 | · | 32.0 | 41.8 | 38.2 | · | 28.9 | |
| P/S | 1.8 | · | · | · | 2.4 | 2.3 | · | 2.6 | 2.4 | 2.5 | · | 1.7 | 2.0 | 1.8 | · | 1.6 | |
| P/B | · | · | · | · | 2.5 | 2.5 | · | 2.6 | 2.5 | 2.6 | · | 1.8 | 2.0 | 1.8 | · | 1.5 | |
| P / Cash Flow | · | · | · | · | · | 130.5 | · | · | · | 168.2 | · | · | · | 416.6 | · | · | |
| EV / Revenue | 2.4 | · | · | · | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.2 | · | 2.3 | 2.7 | 2.5 | · | 2.3 | |
| Earnings Yield | 3.9% | 4.6% | · | 2.4% | 1.8% | 1.8% | · | 2.6% | 2.6% | 2.5% | · | 3.1% | 2.4% | 2.6% | · | 3.5% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $1.85B | $1.72B | $1.56B | $1.33B | $1.22B |
| Marża Brutto % | 27.0% | 26.7% | 26.2% | 26.1% | 27.6% |
| Marża Operacyjna % | 11.9% | 12.1% | 10.5% | 8.8% | 11.1% |
| Zysk netto | $103M | $120M | $91M | $66M | $97M |
| Rozwodniony EPS | $2.89 | $3.36 | $2.69 | $1.99 | $2.91 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 0.6 | 0.6 | 0.7 | 0.6 |
| Wskaźnik bieżący | 3.3 | 3.0 | 2.8 | 2.5 | 2.8 |
| Wskaźnik Szybkości | 1.6 | 1.3 | 1.2 | 1.0 | 1.1 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $105M | $100M | $60M | $42M | $103M |
Właściciele instytucjonalni (13F) 359 emitentów · $4.1B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
359
Wartość posiadanych akcji
$4.1B
Nowe pozycje
46
Zamknięte pozycje
31
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 46 (-12 vs poprzedni kw.) | 31 (-15 vs poprzedni kw.) | 99 (-8 vs poprzedni kw.) | 132 (+20 vs poprzedni kw.) | +3.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $500 307 097 | 5 353 741 | 12,24% | Akcje |
| VANGUARD GROUP INC | $304 790 745 | 3 886 150 | 7,46% | Akcje |
| Invesco Ltd. | $209 985 046 | 2 247 031 | 5,14% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190 681 828 | 2 040 469 | 4,67% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $152 110 279 | 1 627 784 | 3,72% | Akcje |
| NOMURA HOLDINGS INC | $145 263 353 | 1 554 450 | 3,55% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $143 150 728 | 1 531 843 | 3,50% | Akcje |
| STATE STREET CORP | $132 017 182 | 1 413 174 | 3,23% | Akcje |
| MORGAN STANLEY | $125 760 249 | 1 345 748 | 3,08% | Akcje |
| Irenic Capital Management LP | $118 145 004 | 1 264 259 | 2,89% | Akcje |
| EARNEST PARTNERS LLC | $94 246 101 | 1 008 519 | 2,31% | Akcje |
| Hudson Bay Capital Management LP | $93 450 000 | 1 000 000 | 2,29% | Akcje |
| CITADEL ADVISORS LLC | $90 249 618 | 965 753 | 2,21% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $82 199 663 | 879 457 | 2,01% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $80 354 296 | 913 117 | 1,97% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $73 658 598 | 788 214 | 1,80% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $72 769 515 | 778 700 | 1,78% | Akcje |
| UBS Group AG | $61 905 952 | 662 450 | 1,51% | Opcja kupna |
| GOLDMAN SACHS GROUP INC | $53 904 745 | 576 830 | 1,32% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $50 924 830 | 544 942 | 1,25% | Akcje |
| BROWN ADVISORY INC | $50 867 362 | 544 327 | 1,24% | Akcje |
| BANK OF AMERICA CORP /DE/ | $44 289 039 | 473 933 | 1,08% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44 241 006 | 473 419 | 1,08% | Akcje |
| NORTHERN TRUST CORP | $39 548 414 | 423 204 | 0,97% | Akcje |
| CIBC Bancorp USA Inc. | $35 691 453 | 381 931 | 0,87% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $35 390 076 | 378 706 | 0,87% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $34 715 565 | 371 484 | 0,85% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $34 142 985 | 365 361 | 0,84% | Akcje |
| JPMORGAN CHASE & CO | $34 011 651 | 371 349 | 0,83% | Akcje |
| COOKE & BIELER LP | $33 031 304 | 353 465 | 0,81% | Akcje |
| CIBC WORLD MARKET INC. | $30 380 595 | 325 100 | 0,74% | Akcje |
| ROYAL BANK OF CANADA | $30 380 000 | 325 098 | 0,74% | Akcje |
| Point72 (DIFC) Ltd | $28 814 500 | 278 859 | 0,70% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $27 393 372 | 293 134 | 0,67% | Akcje |
| UBS Group AG | $24 646 690 | 263 742 | 0,60% | Akcje |
| Bank of New York Mellon Corp | $23 243 421 | 248 726 | 0,57% | Akcje |
| WELLS FARGO & COMPANY/MN | $23 181 908 | 248 068 | 0,57% | Akcje |
| HEARTLAND ADVISORS INC | $22 449 867 | 240 234 | 0,55% | Akcje |
| CITIGROUP INC | $22 138 492 | 236 902 | 0,54% | Akcje |
| FRANKLIN RESOURCES INC | $22 008 053 | 235 506 | 0,54% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $21 129 606 | 226 106 | 0,52% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $20 803 746 | 222 619 | 0,51% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $20 580 587 | 220 231 | 0,50% | Akcje |
| SAMLYN CAPITAL, LLC | $19 327 890 | 206 826 | 0,47% | Akcje |
| AMERIPRISE FINANCIAL INC | $18 911 073 | 202 364 | 0,46% | Akcje |
| FULLER & THALER ASSET MANAGEMENT, INC. | $18 640 756 | 199 473 | 0,46% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $17 815 755 | 190 645 | 0,44% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $16 939 000 | 181 260 | 0,41% | Akcje |
| Ararat Capital Management LP | $16 731 195 | 179 039 | 0,41% | Akcje |
| Sea Cliff Partners Management, LP | $16 551 210 | 177 113 | 0,40% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Gabelli Funds, LLC I.D. No., GAMCO Asset Management Inc. I.D. No., Teton Advisors, Inc. I.D. No., GGCP, Inc. I.D. No., GAMCO Investors, Inc. I.D. No., Mario J. Gabelli ×2 zgłoszenia | 8 października 2008 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 74 insiderów · 46 dyrektorzy generalni · 22 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Payman Khales | President & CEO | 24 lutego 2026 M | 61 854 | 1 | 0 | $203 067 |
| Joseph W Dziedzic | President & CEO | 11 czerwca 2025 M | 45 807 | 0 | 0 | $0 |
| Thomas J Hook | President & CEO | 10 marca 2017 M | 242 305 | 0 | 0 | $0 |
| Diron Smith | EVP, Chief Financial Officer | 8 maja 2026 M | 12 919 | 1 | 0 | $74 973 |
| Jason K Garland | EVP, Chief Financial Officer | 20 stycznia 2023 A | 16 061 | 0 | 0 | $0 |
| Gary J Haire | EVP & Chief Financial Officer | 16 maja 2018 S | 4 411 | 0 | 0 | $0 |
| Michael Dinkins | Exe VP Chief Financial Officer | 15 stycznia 2016 F | 39 626 | 0 | 0 | $0 |
| Lawrence P Reinhold | Executive VP & CFO | 31 marca 2005 A | 15 834 | 0 | 0 | $0 |
| Andrew Senn | President, Growth & Innovation | 8 września 2026 S | 5 405 | 0 | 1 | $-1 188 230 |
| John A Harris | President, Glob Ops & Manu Tec | 29 czerwca 2026 A | 8 657 | 1 | 0 | $115 500 |
| Jim Stephens | President, CRM & Neuro | 15 maja 2026 M | 5 852 | 0 | 0 | $0 |
| Carter Houghton | President, Electrochem | 31 grudnia 2022 M | 3 681 | 0 | 0 | $0 |
| Joel Becker | President, CRM & Neuro | 22 kwietnia 2022 M | 2 701 | 0 | 0 | $0 |
| Jose Antonio Gonzalez | President, CRM & Neuro | 28 lutego 2019 A | 4 702 | 0 | 0 | $0 |
| Jeremy Friedman | EVP, COO | 28 grudnia 2018 M | 16 514 | 0 | 0 | $0 |
| Kirk K Thor | Chief Human Resources Officer | 15 września 2026 S | 7 153 | 0 | 2 | $-3 981 689 |
| Milo Stephen Metcalf II | US - EVP, Operations | 6 lipca 2026 A | · | 0 | 0 | $0 |
| Tommy P Thomas | VP, Corporate Controller | 18 maja 2026 A | 4 381 | 0 | 2 | $-132 138 |
| Terence Carr | EVP, Qlty & Regulatory Affairs | 24 marca 2026 M | 952 | 0 | 0 | $0 |
| Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | 24 marca 2026 M | 2 434 | 0 | 0 | $0 |
| Sanjiv Arora | SVP, Investor Relations | 7 kwietnia 2025 A | · | 0 | 0 | $0 |
| Margaret Carthy | EVP, Qlty & Regulatory Affairs | 21 lutego 2025 F | 7 686 | 0 | 0 | $0 |
| Mcalister C Marshall II | SVP, Gen Counsel & Secretary | 21 lutego 2025 F | 6 830 | 0 | 0 | $0 |
| Jennifer M Bolt | EVP, Global Operations & ESG | 20 stycznia 2023 A | 25 313 | 0 | 0 | $0 |
| Anthony W Borowicz | SVP Strategy,Corp Dev., IR | 31 grudnia 2021 M | 21 739 | 0 | 0 | $0 |
| Joseph F Flanagan | EVP, Quality & Regulatory Affa | 31 grudnia 2021 M | 12 680 | 0 | 0 | $0 |
| Elizabeth Giddens | SVP, General Counsel | 22 stycznia 2021 A | 678 | 0 | 0 | $0 |
| Michael L Spencer | Chief Ethics & Compliance Of | 28 lutego 2019 A | 7 962 | 0 | 0 | $0 |
| Timothy G Mcevoy | Sr. VP, Gen. Counsel & Sec. | 28 grudnia 2018 M | 32 385 | 0 | 0 | $0 |
| Declan Smyth | Pres., Advanced Surgical, Orth | 16 maja 2018 M | 6 766 | 0 | 0 | $0 |
| Thomas J Mazza | VP, Corporate Controller | 3 stycznia 2018 S | 3 123 | 0 | 0 | $0 |
| Kristin Trecker | Chief Human Resource Officer | 6 lutego 2017 A | 1 757 | 0 | 0 | $0 |
| Andrew P Holman | EVP, Global Sales & Marketing | 15 stycznia 2016 F | 8 281 | 0 | 0 | $0 |
| Mauricio Arellano | EVP, Global Operations | 15 stycznia 2016 F | 42 213 | 0 | 0 | $0 |
| George M Cintra | Exec. VP, CTO | 20 stycznia 2015 F | 6 224 | 0 | 0 | $0 |
| Thomas Kelley Hickman | EVP, Global Sales & Mktg, QiG | 5 stycznia 2015 A | · | 0 | 0 | $0 |
| Michelle Graham | Sr. VP Human Resources | 7 sierpnia 2014 S | 160 | 0 | 0 | $0 |
| Daniel Robert Kaiser | Chief Technology Officer | 31 grudnia 2012 A | · | 0 | 0 | $0 |
| Marco Benedetti | Corp Contr & Treasurer | 5 marca 2012 A | 4 355 | 0 | 0 | $0 |
| Susan H Campbell | Sr. VP, Orthopaedics | 10 marca 2010 A | 15 469 | 0 | 0 | $0 |
| Barbara M Davis | Vice President, Human Resource | 1 stycznia 2010 F | 10 102 | 0 | 0 | $0 |
| Richard M. Farrell | VP, SDI Group | 5 stycznia 2009 A | · | 0 | 0 | $0 |
| John Ayliffe | VP Europe | 11 września 2008 P | 13 727 | 0 | 0 | $0 |
| Patrick Berdoz | Sr. VP Orthopedics | 4 marca 2008 A | 4 419 | 0 | 0 | $0 |
| John T. Farrell | VP, Therapy Delivery | 4 marca 2008 A | 11 290 | 0 | 0 | $0 |
| Larry T Deangelo | Sr.VP, Administration and Secr | 29 grudnia 2006 F | 42 592 | 0 | 0 | $0 |
| Aaron Kapito | Dyrektor | 20 maja 2026 A | 3 338 | 0 | 0 | $0 |
| James Francis Flanagan | Dyrektor | 20 maja 2026 A | 2 377 | 0 | 0 | $0 |
| Cheryl C Capps | Dyrektor | 20 maja 2026 A | 13 669 | 1 | 0 | $106 720 |
| Sheila Antrum | Dyrektor | 20 maja 2026 A | 12 069 | 0 | 0 | $0 |
| Alvin Tyrone Jeffers | Dyrektor | 20 maja 2026 A | 4 552 | 0 | 0 | $0 |
| James F. Hinrichs | Dyrektor | 20 maja 2026 A | 7 424 | 0 | 0 | $0 |
| Pamela G Bailey | Dyrektor | 2 stycznia 2026 M | 54 253 | 0 | 0 | $0 |
| Jean M. Hobby | Dyrektor | 21 maja 2025 A | 3 794 | 0 | 0 | $0 |
| William B Summers JR | Dyrektor | 12 czerwca 2024 G | 44 410 | 0 | 0 | $0 |
| Bill R Sanford | Dyrektor | 18 maja 2022 M | 47 322 | 0 | 0 | $0 |
| Peter H Soderberg | Dyrektor | 20 maja 2020 A | 62 745 | 0 | 0 | $0 |
| Anthony P Bihl III | Dyrektor | 4 stycznia 2016 A | 11 727 | 0 | 0 | $0 |
| Joseph A Miller | Dyrektor | 3 grudnia 2015 M | 23 745 | 0 | 0 | $0 |
| Marcia A Dall | Dyrektor | 5 maja 2015 P | 2 157 | 0 | 0 | $0 |
| Kevin C Melia | Dyrektor | 4 stycznia 2014 A | 21 353 | 0 | 0 | $0 |
| Helena S. Wisniewski | Dyrektor | 1 stycznia 2012 A | 9 610 | 0 | 0 | $0 |
| John P Wareham | Dyrektor | 4 stycznia 2010 A | 12 490 | 0 | 0 | $0 |
| Thomas S Summer | Dyrektor | 19 maja 2008 M | 8 559 | 0 | 0 | $0 |
| Edward F Voboril | Dyrektor | 28 grudnia 2007 F | 206 309 | 0 | 0 | $0 |
| Donald J Spence | · | 20 maja 2026 A | 18 781 | 0 | 0 | $0 |
| Filippo Passerini | · | 20 maja 2026 A | 31 114 | 0 | 0 | $0 |
| Martin C Maxwell | · | 20 maja 2026 A | 25 106 | 0 | 0 | $0 |
| Michael J Coyle | · | 20 maja 2026 A | 3 322 | 0 | 0 | $0 |
| Rudy A Mazzocchi | · | 4 stycznia 2014 A | 4 904 | 0 | 0 | $0 |
| Susan M Bratton | · | 12 czerwca 2013 S | 54 470 | 0 | 0 | $0 |
| Robert E Rich JR | · | 24 lutego 2004 A | · | 0 | 0 | $0 |
| Henry Wendt | · | 24 lutego 2004 A | 286 780 | 0 | 0 | $0 |
| Jose E Almeida | · | 18 lutego 2003 A | 2 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 55 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 2,35% | 32 319 SH | 2 października 2026 | Dziennie |
| IHI · iShares Trust | 0,64% | 162 458 SH | 11 września 2026 | Dziennie |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,47% | 7 528 NS | 31 lipca 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,34% | 72 050 SH | 19 sierpnia 2026 | Dziennie |
| NUSC · Nushares ETF Trust | 0,31% | 33 132 NS | 31 lipca 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,27% | 5 104 SH | 2 października 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,27% | 57 280 SH | 2 października 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 12 984 NS | 31 lipca 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 28 005 NS | 31 lipca 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,25% | 167 580 NS | 31 lipca 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,21% | 29 985 SH | 19 sierpnia 2026 | Dziennie |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1 294 NS | 31 lipca 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,17% | 118 797 SH | 19 sierpnia 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 8 793 NS | 31 lipca 2026 | N-PORT |
| IWM · iShares Trust | 0,14% | 878 135 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,13% | 16 413 NS | 31 lipca 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,13% | 125 NS | 31 lipca 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,12% | 18 562 SH | 2 października 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,11% | 134 676 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 197 334 SH | 19 sierpnia 2026 | Dziennie |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,09% | 1 303 NS | 31 lipca 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,09% | 117 941 NS | 31 lipca 2026 | N-PORT |
| ESML · iShares Trust | 0,08% | 16 744 SH | 11 września 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,07% | 494 632 SH | 19 sierpnia 2026 | Dziennie |
| TEXN · iShares Trust | 0,07% | 103 SH | 11 września 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 16 353 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 3 815 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,05% | 103 523 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,05% | 2 090 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,04% | 2 149 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 389 494 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,04% | 778 797 SH | 19 sierpnia 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,02% | 27 807 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 75 982 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2 370 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 2 002 NS | 31 lipca 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7 546 SH | 19 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,01% | 7 657 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 47 106 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,01% | 10 286 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 9 354 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,00% | 557 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 079 944 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 27 334 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 791 SH | 19 sierpnia 2026 | Dziennie |
| FTLS · First Trust Exchange-Traded Fund III | -0,06% | -12 905 NS | 31 lipca 2026 | N-PORT |
| IJR · iShares Trust | · | 2 072 236 SH | 10 września 2026 | Dziennie |
| IJS · iShares Trust | · | 302 990 SH | 8 września 2026 | Dziennie |
| IWN · iShares Trust | · | 322 095 SH | 11 września 2026 | Dziennie |
| XJR · iShares Trust | · | 4 684 SH | 31 sierpnia 2026 | Dziennie |
| SVAL · iShares Trust | · | 6 867 SH | 3 września 2026 | Dziennie |
| ISCB · iShares Trust | · | 1 455 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 4 450 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 8 779 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 2 149 SH | 1 września 2026 | Dziennie |
ITGR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 15 analityków
TRZYMAJ
Średni cel
$127.00
+0,4%
0 0,0%
Mocne kupno
0 0,0%
Kup
12 80,0%
Trzymaj
1 6,7%
Sprzedaj
2 13,3%
Mocna sprzedaż
12-miesięczny cel cenowy
5 analityków · 2026-10-03Średnia cel $121.80 -3,7%
Teraz
Aktualna cena $126.45
Niski$101.00
Średnia$121.80
Wysoki$127.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| IRTC | $5.73B | -127.7 | 26.2% | -6.0% | -34.8% | 70.6% |
| PLSE | · | · | · | · | · | · |
| CHRN | $2.67B | -51.0 | -15.1% | -70.3% | -53.2% | · |
| ASST | · | -0.1 | 1217.5% | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 4, 2026